Vivani Medical (NASDAQ:VANI – Get Free Report) announced its earnings results on Monday. The company reported ($0.11) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.01), Zacks reports.
Vivani Medical Stock Down 3.5 %
VANI opened at $1.11 on Monday. The business’s fifty day simple moving average is $1.14 and its 200 day simple moving average is $1.21. Vivani Medical has a 52 week low of $1.03 and a 52 week high of $2.22. The stock has a market cap of $65.75 million, a PE ratio of -2.47 and a beta of 3.20.
Wall Street Analyst Weigh In
Separately, HC Wainwright reaffirmed a “buy” rating and issued a $4.00 target price on shares of Vivani Medical in a research note on Wednesday, March 26th.
Vivani Medical Company Profile
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Featured Articles
- Five stocks we like better than Vivani Medical
- Energy and Oil Stocks Explained
- Netflix Poised for Significant Rally as a Safe Haven Stock
- Why is the Ex-Dividend Date Significant to Investors?
- Lululemon Pulls Back Into Classic Dip-Buying Opportunity
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Cintas Delivers Earnings Beat, Signals More Growth Ahead
Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.
